Where Creativity and Science Collide
THE COMPANY THAT FINDS CREATIVE SOLUTIONS FOR MODERN ANTIBODY TECHNOLOGIES
Creasallis Ltd is a Cambridge, UK-based company with an expert team of antibody engineers in the biopharmaceutical industry. We provide novel protein engineering solutions for antibody-based therapeutics offering enhanced efficacy, safety and lower cost of goods for antibody based drugs.
At Creasallis we believe that antibody-based therapeutics can be greatly enhanced with creative engineering. Our team of antibody engineers have over 15 years of experience in the biopharmaceutical industry developing antibody-based therapeutics and implementing engineering solutions to antibody bottlenecks.
At Creasallis, we believe that by combining our unique insights into antibody structure with molecular biology tools, we can create the second generation of antibody molecules that will out perform the current therapies. Our vision is to use these therapies to save lives and we believe in creating a dynamic and productive organisation to realise this.
Smart solutions are at the core of all that we do at Creasallis. Our first technology is the CreaTap™ Tumour Antibody Penetration technology that improves penetrability of antibodies into the tumour microenvironment. CreaTap™ is unique with full freedom to operate that is fully owned by Creasallis. Contact us now to hear more about the value of CreaTap™.
"The world we have made as a result of the level of thinking we have done thus far creates problems we cannot solve at the same level of thinking at which we created them."
Creasallis wins top accelerator award
Creasallis has won a place as part of cohort 4 on the accelerate@Babraham accelerator. this will enable Creasallis to collaborate and start up its next generation antibody engineering capabilities